002409:SZSEJiangsu Yoke Technology Co., Ltd. Analysis
Data as of 2026-03-12 - not real-time
CN¥89.03
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Jiangsu Yoke Technology posted a robust 24.7% revenue growth and an 11% profit margin, underscoring solid operating performance. However, its trailing PE of 46.1 is well above the industry average of 34.6, and the DCF‑derived fair value of ¥62.5 is far below the current market price of ¥89.0, indicating the stock is materially overvalued at present. The company carries a high debt‑to‑equity ratio of 44.4% and negative free cash flow, which tempers the attractiveness of its dividend (0.64% yield) despite a modest 30% payout ratio.
On the technical side, the price sits just below the 20‑day SMA (¥91.5) but above the 50‑day SMA (¥89.0), with bullish trend direction and strong support at ¥84.7. Yet the MACD remains bearish and the 30‑day volatility is elevated at ~50%, suggesting short‑term price swings. Volume is increasing, reinforcing the current price action, while a low beta of 0.12 points to limited systematic market risk.
On the technical side, the price sits just below the 20‑day SMA (¥91.5) but above the 50‑day SMA (¥89.0), with bullish trend direction and strong support at ¥84.7. Yet the MACD remains bearish and the 30‑day volatility is elevated at ~50%, suggesting short‑term price swings. Volume is increasing, reinforcing the current price action, while a low beta of 0.12 points to limited systematic market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near strong support at ¥84.7
- Bearish MACD histogram
- Increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 24.7% YoY revenue growth
- Forward EPS growth to ¥3.16
- Industry tailwinds in semiconductor materials
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Strategic position in high‑growth semiconductor equipment sector
- Potential for debt reduction as cash flow improves
- Long‑term valuation gap if price reverts toward DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth24.70%
Profit Margin11.03%
P/E Ratio46.1
ROE10.11%
ROA5.16%
Debt/Equity44.42
P/B Ratio5.4
Op. Cash FlowCN¥1.2B
Free Cash FlowCN¥-448872864
Industry P/E34.6
Technical Analysis
TrendBullish
RSI46.7
SupportCN¥84.67
ResistanceCN¥99.53
MA 20CN¥91.52
MA 50CN¥88.96
MA 200CN¥69.62
MACDBearish
VolumeIncreasing
Fear & Greed Index76.54
Valuation
Fair ValueCN¥62.49
Target PriceCN¥89.15
Upside/Downside0.13%
GradeOvervalued
TypeGrowth
Dividend Yield0.64%
Risk Assessment
Beta0.12
Volatility50.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.